» Articles » PMID: 20442861

Keratinocytes Determine Th1 Immunity During Early Experimental Leishmaniasis

Abstract

Experimental leishmaniasis is an excellent model system for analyzing Th1/Th2 differentiation. Resistance to Leishmania (L.) major depends on the development of a L. major specific Th1 response, while Th2 differentiation results in susceptibility. There is growing evidence that the microenvironment of the early affected tissue delivers the initial triggers for Th-cell differentiation. To analyze this we studied differential gene expression in infected skin of resistant and susceptible mice 16h after parasite inoculation. Employing microarray technology, bioinformatics, laser-microdissection and in-situ-hybridization we found that the epidermis was the major source of immunomodulatory mediators. This epidermal gene induction was significantly stronger in resistant mice especially for several genes known to promote Th1 differentiation (IL-12, IL-1beta, osteopontin, IL-4) and for IL-6. Expression of these cytokines was temporally restricted to the crucial time of Th1/2 differentiation. Moreover, we revealed a stronger epidermal up-regulation of IL-6 in the epidermis of resistant mice. Accordingly, early local neutralization of IL-4 in resistant mice resulted in a Th2 switch and mice with a selective IL-6 deficiency in non-hematopoietic cells showed a Th2 switch and dramatic deterioration of disease. Thus, our data indicate for the first time that epidermal cytokine expression is a decisive factor in the generation of protective Th1 immunity and contributes to the outcome of infection with this important human pathogen.

Citing Articles

Cutaneous leishmaniasis and iron metabolism: current insights and challenges.

Assouab A, Kihel A, Rouahi M, Larribau M, Karim Z, Akarid K Front Immunol. 2024; 15:1488590.

PMID: 39691716 PMC: 11649654. DOI: 10.3389/fimmu.2024.1488590.


The immune response in canine and human leishmaniasis and how this influences the diagnosis- a review and assessment of recent research.

Ivanescu L, Andronic B, Grigore-Hristodorescu S, Martinescu G, Mindru R, Miron L Front Cell Infect Microbiol. 2023; 13:1326521.

PMID: 38149009 PMC: 10749942. DOI: 10.3389/fcimb.2023.1326521.


Dissection of the macrophage response towards infection by the -viral endosymbiont duo and dynamics of the type I interferon response.

Bekkar A, Isorce N, Snaka T, Claudinot S, Desponds C, Kopelyanskiy D Front Cell Infect Microbiol. 2022; 12:941888.

PMID: 35992159 PMC: 9386148. DOI: 10.3389/fcimb.2022.941888.


Eosinophils, but Not Type 2 Innate Lymphoid Cells, Are the Predominant Source of Interleukin 4 during the Innate Phase of Infection.

Sasse C, Barinberg D, Obermeyer S, Debus A, Schleicher U, Bogdan C Pathogens. 2022; 11(8).

PMID: 35894051 PMC: 9331382. DOI: 10.3390/pathogens11080828.


Visceral Leishmaniasis and the Skin: Dermal Parasite Transmission to Sand Flies.

Arumugam S, Scorza B, Petersen C Pathogens. 2022; 11(6).

PMID: 35745464 PMC: 9228576. DOI: 10.3390/pathogens11060610.


References
1.
van Zandbergen G, Hermann N, Laufs H, Solbach W, Laskay T . Leishmania promastigotes release a granulocyte chemotactic factor and induce interleukin-8 release but inhibit gamma interferon-inducible protein 10 production by neutrophil granulocytes. Infect Immun. 2002; 70(8):4177-84. PMC: 128123. DOI: 10.1128/IAI.70.8.4177-4184.2002. View

2.
Chomarat P, Banchereau J, Davoust J, Palucka A . IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat Immunol. 2001; 1(6):510-4. DOI: 10.1038/82763. View

3.
Sypek J, Chung C, Mayor S, Subramanyam J, Goldman S, Sieburth D . Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J Exp Med. 1993; 177(6):1797-802. PMC: 2191036. DOI: 10.1084/jem.177.6.1797. View

4.
Constant S, Brogdon J, Piggott D, Herrick C, Visintin I, Ruddle N . Resident lung antigen-presenting cells have the capacity to promote Th2 T cell differentiation in situ. J Clin Invest. 2002; 110(10):1441-8. PMC: 151814. DOI: 10.1172/JCI16109. View

5.
Moskowitz N, Brown D, Reiner S . Efficient immunity against Leishmania major in the absence of interleukin-6. Infect Immun. 1997; 65(6):2448-50. PMC: 175340. DOI: 10.1128/iai.65.6.2448-2450.1997. View